Skin and tanning

What the studies show, and what they do not.

The topical GHK-Cu studies and Melanotan II tanning studies looked at different products and outcomes. They do not support a routine cosmetic injection plan. [1–5]

Source-based editorial review; independent clinical review pending. Read the sources.

Evidence by peptide

• GHK-Cu: Small studies of specific topical products report mixed findings. They do not establish that injections improve skin or hair. FDA flags limited human safety data for injectable GHK-Cu. [1–3]
• Melanotan II: The cited pigmentation pilot enrolled three men. That is not evidence of safe routine tanning use. Australia's TGA warns against Melanotan II tanning products. [4,5]

Common Questions

• Are GHK-Cu injections better than a serum?

  The cited skin studies tested topical products, not a comparison with injections. They cannot establish that injections work better. FDA separately flags injectable safety concerns. [1–3]

• Can Melanotan II tanning replace sun protection?

  No. TGA advises that tanning products containing melanotan are not a substitute for sun protection and warns against their use. [6]

• Does this guide recommend a cosmetic injection dose?

  No. The small studies and regulator warnings cited here do not establish a safe routine injection plan for these cosmetic goals. [1–5]

Sources and study limits

1. Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters. Badenhorst T, Svirskis D, Merrilees M, Bolke L, Wu Z. (2016)
2. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Miller TR, Wagner JD, Baack BR, Eisbach KJ. (2006)
3. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks U.S. Food and Drug Administration
4. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study Dorr RT et al. (1996)
5. Melanotan II tanning peptide products found to be inconsistently dosed Therapeutic Goods Administration (2026)
6. Don't risk using tanning products containing melanotan Therapeutic Goods Administration (2025)

Related Comparisons

• GHK-Cu topical vs GHK-Cu injectable: Topical skin studies do not establish the effects or safety of injections.

← Browse all peptides

Educational evidence summary. FDA approval, investigational status, and compounding are separate categories. Use the current label and a licensed clinician for patient-specific decisions.

vialprep research · Sources: PubMed, FDA, peer-reviewed trials · How we verify